Bradway's Patient Dealmaking Brings Onyx To Amgen

Now watching

Next video starts in : 7 Play

Bradway's Patient Dealmaking Brings Onyx To Amgen

Bradway's Patient Dealmaking Brings Onyx To Amgen
Replay video
Up next

Consumer prices unexpectedly fall; Fed decision day; Nelson Peltz takes aim at DuPont

Consumer prices unexpectedly fall; Fed decision day; Nelson Peltz takes aim at DuPont Up next

Consumer prices unexpectedly fall; Fed decision day; Nelson Peltz takes aim at DuPont

Unlock your personal NFL Now stream by signing in to NFL.com

Bradway's Patient Dealmaking Brings Onyx To Amgen

Wochit 0:56 mins

Investment banker turned biotech chief executive, Robert Bradway, staked a claim as a savvy dealmaker with Amgen Inc's successful acquisition of Onyx Pharmaceuticals Inc for more than $10 billion. Facebook's stock price struck an all-time high since the company first went public in May 2012. At the close of the market, Facebook shares were trading at $41.34, which is an increase of 1.9 percent since Friday. Bill Ackman's Pershing Square has sold its entire stake in J.C. Penney. The hedge fund had been the largest shareholder in the struggling retailer's stock, owning 39.1 million shares, or 18% of the shares outstanding.

View Comments (0)